ArticlePloS one2022
Use of machine learning to examine disparities in completion of substance use disorder treatment.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Utilizing categorical boosting and SHAP to understand key predictors of frequency of use at discharge for completed substance abuse treatments in TEDS-D.Machine learning. Health · 2026Article
- What We Do Matters: A Documentary Style Video to Address Healthcare Stigma Toward People Who Use Substances.Substance use & addiction journal · 2026Article
- Subgroup identification of disparities in buprenorphine discontinuation in opioid-use disorder: A Virtual Twins machine learning approach using nationwide United States claims data, 2006-2022.PLOS mental health · 2026Article
- Association Between Loneliness and Mental Health Treatment Utilization in a Prison-Based Substance Use Treatment Population.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2025Article
- Toward precision stroke rehabilitation: an integrated causal machine learning and clinician feedback approach.JAMIA open · 2025Article
- Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative study.medRxiv : the preprint server for health sciences · 2024Article
- Exploring predictors of substance use disorder treatment engagement with machine learning: The impact of social determinants of health in the therapeutic landscape.Journal of substance use and addiction treatment · 2024Article
- Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies.Critical care medicine · 2024Review
- Assessing a pilot scheme of intensive support and assertive linkage in levels of engagement, retention, and recovery capital for people in recovery housing using quasi-experimental methods.Journal of substance use and addiction treatment · 2024Article
- Factors predicting access to medications for opioid use disorder for housed and unhoused patients: A machine learning approach.PloS one · 2024Article
- Determinants of outpatient substance use disorder treatment length-of-stay and completion: the case of a treatment program in the southeast U.S.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this work is to examine disparities in the completion of substance use disorder treatment in the U.S. Our data is from the Treatment Episode Dataset Discharge (TEDS-D) datasets from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) for 2017-2019. We apply a two-stage virtual twins model (random forest + decision tree) where, in the first stage (random forest), we determine differences in treatment completion probability associated with race/ethnicity, income source, no co-occurrence of mental health disorders, gender (biological), no health insurance, veteran status, age, and primary substance (alcohol or opioid). In the second stage (decision tree), we identify subgroups associated with probability differences, where such subgroups are more or less likely to complete treatment. We find the subgroups most likely to complete substance use disorder treatment, when the subgroup represents more than 1% of the sample, are those with no mental health condition co-occurrence (4.8% more likely when discharged from an ambulatory outpatient treatment program, representing 62% of the sample; and 10% more likely for one of the more specifically defined subgroups representing 10% of the sample), an income source of job-related wages/salary (4.3% more likely when not having used in the 30 days primary to discharge and when primary substance is not alcohol only, representing 28% of the sample), and white non-Hispanics (2.7% more likely when discharged from residential long-term treatment, representing 9% of the sample). Important implications are that: 1) those without a co-occurring mental health condition are the most likely to complete treatment, 2) those with job related wages or income are more likely to complete treatment, and 3) racial/ethnicity disparities persist in favor of white non-Hispanic individuals seeking to complete treatment. Thus, additional resources may be needed to combat such disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.